ULBI
Ultralife Corporation
Related News
SEC Filings
Earnings Trend
Screening
Compare
Economic Calendar
We use cookies in accordance with European GDPR standards to improve site usability, analytics, and deliver personalized advertising.Learn moreCookie Settings
Ultralife Corporation maintains a Buy rating, supported by strong working capital, declining debt, and improving profitability despite recent cash flow concerns. ULBI's Q2-2026 results show significan
